Ophthalmotoxicity induced by antibody-drug conjugates: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)
ADCs had different profiles of ophthalmotoxicity. Our pharmacovigilance study suggested increased reporting of ophthalmotoxicity associated with ADCs.
Authors
- Shan Yang (ORCID: https://orcid.org/0000-0002-3564-5111)
- Junyan Wu
- Wenxia Zhao (ORCID: https://orcid.org/0009-0008-6987-2524)
- Lei Ding (ORCID: https://orcid.org/0000-0002-0097-3000)
- Min Huang
- Xin Feng (ORCID: https://orcid.org/0000-0002-7345-624X)
- Guosen Yuan
- Zhichao He
Institutions
- Sun Yat-sen University (CN)
- Guangdong Medical College (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1080/14740338.2025.2491125
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China